All stock reportsM&M evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-21T23:40:45.053995+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 1948061500000.0
- net_income
- 170988500000.0
- operating_cash_flow
- 141600200000.0
- free_cash_flow
- 45545700000.0
- total_assets
- 1489146385000.0
- total_liabilities
- 1043447935000.0
- total_equity
- 445698450000.0
- cash
- 114267545000.0
- total_debt
- 477245830000.0
- revenue_growth
- 0.2516034860297063
- earnings_growth
- 0.3225089140002011
- net_margin
- 0.087773666283123
- roe
- 0.38364167521785186
- debt_to_equity
- 1.0707818930041153
- cash_conversion
- 0.8281270377832427
- free_cash_flow_margin
- 0.023380011360010965
- trailing_pe
- 21.5933
- forward_pe
- 21.692
- peg_ratio
- 1.2638
- price_to_book
- 4.1555
- dividend_yield
- 0.0
Other positional research
Research only
2 opportunity assessments; compare evidence and conditions below.
Mean Reversion Capitulation
Research only. Direction: LONG.
Tests recovery after an extreme price/volume dislocation
- No active, unexpired validation authority for this exact strategy and horizon.
- A source-backed entry, invalidation, exit and cost plan is not supplied.
- Eligible expression
- None selected
- Expression comparison
- No eligible instrument selected.
- Invalidation
- Continued trend momentum breakdown
- Entry rule
- Not supplied
- Entry range (INR)
- Not supplied
- Exit / review rule
- Not supplied
- Planned exit
- Not supplied
- Plan valid until
- Not supplied
- Promotion reference
- Not supplied
- No reader capital or loss budget supplied
Price Dislocation
Research only. Direction: LONG.
Flags large price dislocations for research without asserting unsupported fundamental quality
- No active, unexpired validation authority for this exact strategy and horizon.
- A source-backed entry, invalidation, exit and cost plan is not supplied.
- Eligible expression
- None selected
- Expression comparison
- No eligible instrument selected.
- Invalidation
- Continued price deterioration or adverse fundamental evidence
- Entry rule
- Not supplied
- Entry range (INR)
- Not supplied
- Exit / review rule
- Not supplied
- Planned exit
- Not supplied
- Plan valid until
- Not supplied
- Promotion reference
- Not supplied
- No reader capital or loss budget supplied
Decision provenance and limitations
- Decision ID
- decision-d809ef22c32a7c97ee749e62b66e15b40eec7c1a310bf24971f307c20611a92d
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 7ebfaa043da6ac761daed387dc40f20afeb860db57b8321217c076d537af4886
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 0dbf22f925df35292a4d68f5cb3e8862d5d8c008d9f6664738a7fea0700f827d
- daily-price: 0979553c0b78132a95a43400028ca53080a16dd42695d20164fc339acf06999a
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 2860.00.
- The trailing 5-session price return was -4.11%.
- The trailing 20-session price return was -10.34%.
- The trailing 60-session price return was -7.82%.
- The trailing 250-session price return was -18.13%.
- Average cached traded value over twenty sessions was INR 6,551,644,739.
- The closing price was -23.99% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-21T23:40:45.053995+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.2516034860297063.
- The cached financial metric net margin is 0.087773666283123.
- The cached financial metric roe is 0.38364167521785186.
- The cached financial metric debt to equity is 1.0707818930041153.
- The cached financial metric cash conversion is 0.8281270377832427.
- The cached financial metric free cash flow margin is 0.023380011360010965.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.